Xu J - Search Results

1

The role of CDR1as/ciRS-7 in cardio-cerebrovascular diseases.

Shao Y, Xu J, Liang B, Zhang S, Chen W, Wang Y, Xing D. Shao Y, et al. Among authors: xu j. Biomed Pharmacother. 2023 Nov;167:115589. doi: 10.1016/j.biopha.2023.115589. Epub 2023 Sep 28. Biomed Pharmacother. 2023. PMID: 37776642 Free article. Review.

2

Emodin lows NPC1L1-mediated cholesterol absorption as an uncompetitive inhibitor.

Meng J, Xu J, Yang S, Liu W, Zeng J, Shi L, Chang J, Zhang R, Xing D. Meng J, et al. Among authors: xu j. Bioorg Med Chem Lett. 2022 Nov 1;75:128974. doi: 10.1016/j.bmcl.2022.128974. Epub 2022 Sep 5. Bioorg Med Chem Lett. 2022. PMID: 36064125

3

Review of preclinical data of PF-07304814 and its active metabolite derivatives against SARS-CoV-2 infection.

Chen W, Shao Y, Peng X, Liang B, Xu J, Xing D. Chen W, et al. Among authors: xu j. Front Pharmacol. 2022 Nov 11;13:1035969. doi: 10.3389/fphar.2022.1035969. eCollection 2022. Front Pharmacol. 2022. PMID: 36438815 Free PMC article. Review.

4

MST1: A future novel target for cardiac diseases.

Shao Y, Wang Y, Sun L, Zhou S, Xu J, Xing D. Shao Y, et al. Among authors: xu j. Int J Biol Macromol. 2023 Jun 1;239:124296. doi: 10.1016/j.ijbiomac.2023.124296. Epub 2023 Apr 1. Int J Biol Macromol. 2023. PMID: 37011743 Review.

5

The potential role and mechanism of circRNA/miRNA axis in cholesterol synthesis.

Chen W, Xu J, Wu Y, Liang B, Yan M, Sun C, Wang D, Hu X, Liu L, Hu W, Shao Y, Xing D. Chen W, et al. Among authors: xu j. Int J Biol Sci. 2023 May 29;19(9):2879-2896. doi: 10.7150/ijbs.84994. eCollection 2023. Int J Biol Sci. 2023. PMID: 37324939 Free PMC article. Review.

6

Growth differentiation factor 11: A new hope for the treatment of cardiovascular diseases.

Shao Y, Wang Y, Xu J, Yuan Y, Xing D. Shao Y, et al. Among authors: xu j. Cytokine Growth Factor Rev. 2023 Jun-Aug;71-72:82-93. doi: 10.1016/j.cytogfr.2023.06.007. Epub 2023 Jun 30. Cytokine Growth Factor Rev. 2023. PMID: 37414617 Review.

7

Unlocking the potential of targeting histone-modifying enzymes for treating IBD and CRC.

Liang B, Wang Y, Xu J, Shao Y, Xing D. Liang B, et al. Among authors: xu j. Clin Epigenetics. 2023 Sep 11;15(1):146. doi: 10.1186/s13148-023-01562-1. Clin Epigenetics. 2023. PMID: 37697409 Free PMC article. Review.

8

Epidermal growth factor receptor dual-target inhibitors as a novel therapy for cancer: A review.

Wang C, Zhang Y, Zhang T, Xu J, Yan S, Liang B, Xing D. Wang C, et al. Among authors: xu j. Int J Biol Macromol. 2023 Dec 31;253(Pt 7):127440. doi: 10.1016/j.ijbiomac.2023.127440. Epub 2023 Oct 14. Int J Biol Macromol. 2023. PMID: 37839594 Review.

9

A novel nanobody-based HER2-targeting antibody exhibits potent synergistic antitumor efficacy in trastuzumab-resistant cancer cells.

Liu X, Luan L, Liu X, Jiang D, Deng J, Xu J, Yuan Y, Xing J, Chen B, Xing D, Huang H. Liu X, et al. Among authors: xu j. Front Immunol. 2023 Oct 25;14:1292839. doi: 10.3389/fimmu.2023.1292839. eCollection 2023. Front Immunol. 2023. PMID: 37954614 Free PMC article.

10

The clinical development of antibody-drug conjugates for non-small cell lung cancer therapy.

Liu X, Deng J, Zhang R, Xing J, Wu Y, Chen W, Liang B, Xing D, Xu J, Zhang M. Liu X, et al. Among authors: xu j. Front Immunol. 2023 Dec 11;14:1335252. doi: 10.3389/fimmu.2023.1335252. eCollection 2023. Front Immunol. 2023. PMID: 38162667 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

61,897 results

Search Page